Abu dhabi: Saeed bin Mubarak Al Hajeri, Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, has officially launched the Emirates Drug Establishment at the World Health Expo 2026. The launch aims to regulate and develop the pharmaceutical and medical sector in the UAE, while advancing the Establishment’s strategic objectives.
According to Emirates News Agency, the event was attended by Ahmed Ali Al Sayegh, Minister of Health and Prevention; Fatima Al Kaabi, Director General of the Establishment; and several senior health sector leaders. His Excellency reviewed key national projects showcased under the ‘Emirates Health’ Pavilion, which are designed to strengthen pharmaceutical security, support innovation, and ensure the sustainability of medical products.
The Emirates Drug Establishment introduced its Holistic National Manufacturing Project, a strategic initiative focusing on developing the national pharmaceutical ecosystem. The project aims to enhance the UAE’s pharmaceutical industrial capacity and competitiveness and encourages research and development within the country. It provides a framework for localising the production of advanced medicines and other products within an integrated system.
The project supports the ‘One Health’ approach, linking human, animal, and environmental health. It prioritises developing an integrated industrial infrastructure covering all stages of the pharmaceutical value chain, ensuring product quality and safety. Dr. Ruqaya Al Bastaki highlighted that this integrated manufacturing project aligns regulatory and industrial efforts while promoting domestic production to international standards.
The Emirates Drug Establishment emphasised that this project is part of broader national initiatives to bolster pharmaceutical security and build a robust, sustainable national pharmaceutical system. To date, 37 facilities have been licensed for the production of human pharmaceutical and medical products by the Establishment.